Use access key #2 to skip to page content.
$39.58 3.08 (8.44%)
10/13/2008 4:03 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar Rifino (< 20) Submitted: 1/26/07 2:38 PM : Outperform Start Price: $50.60 AZN Score: 14.85

The company is a very progressive company and has worked towards improving employee loyalty and satisfaction. It is very customer oriented and this should pay dividends over the long haul.

Report this Post Replies: 0 | Reply

Featured Broker Partners